Crescent Biopharma Statistics
NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.49-0.08 (-0.59%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 13.49 0.00%
Crescent Biopharma by the numbers
Crescent Biopharma has a market capitalization of $501.1 million based on 37.14M shares outstanding. With trailing EPS of $-7.63, Crescent Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.3% below its 50-day average and 14.3% below its 200-day average.
Average daily trading volume is 383.95K shares, or about $5.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CBIO valuation vs. peer median
| Metric | CBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $501.11M | $515.17M | -3% |
| Avg. volume | 383.95K | 591.70K | -35% |
Peer median across 8 companies: PBYI, ACRS, EOLS, DRUG, ALT, NGNE, MPLT, OCS.
Valuation
- Market cap
- $501.11M
- EPS (TTM)
- $-7.63
- Shares outstanding
- 37.14M
Price and trading
- Previous close
- 13.57
- Open
- 13.47
- Day range
- 13.27 – 14.18
- 52-week range
- 8.72 – 27.41
- 52-week change
- +19.49%
- Beta
- —
- Volume
- 1.05M
- Average volume
- 383.95K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 501.11M
- Forward Pe
- -5.13
- Eps
- -7.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.41
- Week52 Low
- 8.72
- Avg Volume
- 383.95K
- Shares Outstanding
- 37.14M
- Ma50
- 16.71
- Ma200
- 15.74
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -50.78%
- Pct From52w Low
- 54.70%